i-ReMeta

What is i-ReMeta?

i-ReMeta is a “super exosome” derived from iPSCs (induced pluripotent stem cells). It offers embryonic stem cell–level regenerative potential, containing multiple signaling factors that support immune modulation, damaged cell repair, and tissue regeneration. This positions i-ReMeta as a promising approach across diverse applications, including anti-aging and neural repair.

What is iPSC?

iPSCs are created through cellular reprogramming, which “rewinds” mature cells back to a youthful, embryonic-like state, restoring their ability to regenerate multiple tissues and organs. This technology was developed by Japanese scientist Shinya Yamanaka in 2006 and was recognized with the 2012 Nobel Prize in Physiology or Medicine.

What’s the Difference Between Exosomes and “Super Exosomes”?

Research indicates that super exosomes secreted by iPSCs, which have higher differentiation potential, contain more diverse protein and nucleic acid signaling molecules compared with exosomes secreted by mature somatic cells.

As a result, they play a more critical role in cell metabolism, tissue development, tissue regeneration, and anti-aging applications.